Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Type 2 diabetes mellitus.~* Cardiovascular disease~* Uninterrupted anti-diabetic treatment for at least 8 weeks before enrolment~Exclusion Criteria:~* Patients with type 1 diabetes or diabetes insipidus~* Patients with 3 or more oral anti-hyperglycaemic drugs with or without insulin and/or poorly controlled diabetes~* Any clinically significant illness, which would compromise the patient's safety and their participation in the study

- Gender: ALL
- Minimum Age: 45 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): dapagliflozin 10 mg tablet
- 2 (Type: PLACEBO_COMPARATOR): matching placebo tablet

Based on this trial design, predict the completion outcome and termination type (if applicable).